The Inhibition of Serine Proteases by Serpins Is Augmented by Negatively Charged Heparin: A Concise Review of Some Clinically Relevant Interactions

• Published in: International journal of molecular sciences Vol. 25; no. 3; p. 1804
• Main Authors: Chan, Edward D, King, Paul T, Bai, Xiyuan, Schoffstall, Allen M, Sandhaus, Robert A, Buckle, Ashley M
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.02.2024
• Subjects: Anticoagulants; Binding sites; C1-esterase inhibitor; Carbon; Development and progression; Enzymes; glycosaminoglycans; Health aspects; heparin; Heparin - chemistry; Icatibant; Infection; Molecular weight; Neutrophils; Peptides; Polysaccharides; Prostate cancer; Protease inhibitors; Serine; serine protease; Serine Proteases; Serine Proteinase Inhibitors - metabolism; serpin; Serpins - metabolism; Thrombin; Thrombin - metabolism; Thromboembolism; Thrombolytic drugs; TMPRSS2; Australia; C1-esterase inhibitor; glycosaminoglycans; heparin; SARS-CoV-2; serpin; TMPRSS2; antithrombin III; serine protease
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25031804

Serine proteases are members of a large family of hydrolytic enzymes in which a particular serine residue in the active site performs an essential role as a nucleophile, which is required for their proteolytic cleavage function. The array of functions performed by serine proteases is vast and includes, among others, the following: the ability to fight infections; the activation of blood coagulation or blood clot lysis systems; the activation of digestive enzymes; and reproduction. Serine protease activity is highly regulated by multiple families of protease inhibitors, known collectively as the SERine Protease INhibitor (SERPIN). The serpins use a conformational change mechanism to inhibit proteases in an irreversible way. The unusual conformational change required for serpin function provides an elegant opportunity for allosteric regulation by the binding of cofactors, of which the most well-studied is heparin. The goal of this review is to discuss some of the clinically relevant serine protease-serpin interactions that may be enhanced by heparin or other negatively charged polysaccharides. The paired serine protease-serpin in the framework of heparin that we review includes the following: thrombin-antithrombin III, plasmin-anti-plasmin, C1 esterase/kallikrein-C1 esterase inhibitor, and furin/TMPRSS2 (serine protease Transmembrane Protease 2)-alpha-1-antitrypsin, with the latter in the context of COVID-19 and prostate cancer.